Paloma Partners’s MacroGenics MGNX Stock Holding History

Paloma Partners’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,536	Closed	-$207K	–	2019
2019 Q1	$207K	Buy	+11,536	New	+$199K	0.01%	1510

Other funds holding MGNX

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paloma Partners's MGNX Position: Q2 2019 in Review

Paloma Partners sold out of MacroGenics (MGNX) in Q2 2019, closing a stake of 11,536 shares — an estimated $207K sold.

Paloma Partners first reported a position in MGNX in Q1 2019 and held it in 1 quarter. The position peaked at $207K in Q1 2019. 130 funds tracked by Wall St. Rank hold MGNX as of Q2 2019.

Paloma Partners reported no remaining MacroGenics position as of Q2 2019 after selling out during the quarter.
Paloma Partners sold 11,536 MacroGenics shares in Q2 2019, an estimated $207K.
Paloma Partners first reported a position in MacroGenics in Q1 2019 and held it in 1 quarter.
Paloma Partners's MacroGenics position peaked at $207K in Q1 2019.
130 funds tracked by Wall St. Rank held MacroGenics as of Q2 2019.

Based on Paloma Partners's 13F filing for Q2 2019, filed 14 Aug 2019.